Vancomycin, a glycopeptide antibiotic, was used as the first-line drug in treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
万古霉素是目前临床上用于治疗由甲氧西林耐药金葡菌(MRSA)引起的严重感染疾病的首选药物。
AIM: to study the effect of levofloxacin, vancomycin, rifampin, azithromycin, tobramycin and chloramphenicol concentration on selection of resistant mutants of staphylococcus aureus ATCC29213.
目的：了解左氧氟沙星、万古霉素、利福平、氯霉素、妥布霉素、阿齐霉素在不同浓度时对金黄色葡萄球菌atcc 29213耐药突变株选择的影响。
In recent years, vancomycin sensitivity of the Staphylococcus aureus has been dropped gradually in the world, and the medicine-resistant strains appear one after another in various countries.
近年来金黄色葡萄球菌对万古霉素的敏感性逐渐下降，并在各国相继出现了耐药菌株。
To investigate the changes in pathogenicity, toxicity and pathological features of Staphylococcus aureus resistant to vancomycin for clinical reference in diagnosis and treatment.
目的了解金葡菌对万古霉素耐药后毒力和致病性变化规律及病变特征，为临床正确诊断和合理治疗奠定基础。
To investigate the changes in pathogenicity, toxicity and pathological features of Staphylococcus aureus resistant to vancomycin for clinical reference in diagnosis and treatment.
目的了解金葡菌对万古霉素耐药后毒力和致病性变化规律及病变特征，为临床正确诊断和合理治疗奠定基础。
应用推荐